A citation-based method for searching scientific literature

Thereasa A Rich, Ashley H Woodson, Jennifer Litton, Banu Arun. J Surg Oncol 2015
Times Cited: 19







List of co-cited articles
142 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Breast-cancer risk in families with mutations in PALB2.
Antonis C Antoniou, Silvia Casadei, Tuomas Heikkinen, Daniel Barrowdale, Katri Pylkäs, Jonathan Roberts, Andrew Lee, Deepak Subramanian, Kim De Leeneer, Florentia Fostira,[...]. N Engl J Med 2014
513
31

Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies.
A Antoniou, P D P Pharoah, S Narod, H A Risch, J E Eyfjord, J L Hopper, N Loman, H Olsson, O Johannsson, A Borg,[...]. Am J Hum Genet 2003
26

Truncating mutations in the Fanconi anemia J gene BRIP1 are low-penetrance breast cancer susceptibility alleles.
Sheila Seal, Deborah Thompson, Anthony Renwick, Anna Elliott, Patrick Kelly, Rita Barfoot, Tasnim Chagtai, Hiran Jayatilake, Munaza Ahmed, Katarina Spanova,[...]. Nat Genet 2006
503
21


Lifetime cancer risks in individuals with germline PTEN mutations.
Min-Han Tan, Jessica L Mester, Joanne Ngeow, Lisa A Rybicki, Mohammed S Orloff, Charis Eng. Clin Cancer Res 2012
470
21

Meta-analysis of BRCA1 and BRCA2 penetrance.
Sining Chen, Giovanni Parmigiani. J Clin Oncol 2007
21

Frequency and spectrum of cancers in the Peutz-Jeghers syndrome.
Nicholas Hearle, Valérie Schumacher, Fred H Menko, Sylviane Olschwang, Lisa A Boardman, Johan J P Gille, Josbert J Keller, Anne Marie Westerman, Rodney J Scott, Wendy Lim,[...]. Clin Cancer Res 2006
455
21

Beyond BRCA: new hereditary breast cancer susceptibility genes.
P Economopoulou, G Dimitriadis, A Psyrri. Cancer Treat Rev 2015
102
21

PALB2, which encodes a BRCA2-interacting protein, is a breast cancer susceptibility gene.
Nazneen Rahman, Sheila Seal, Deborah Thompson, Patrick Kelly, Anthony Renwick, Anna Elliott, Sarah Reid, Katarina Spanova, Rita Barfoot, Tasnim Chagtai,[...]. Nat Genet 2007
670
15

Genetics, genomics, and cancer risk assessment: State of the Art and Future Directions in the Era of Personalized Medicine.
Jeffrey N Weitzel, Kathleen R Blazer, Deborah J MacDonald, Julie O Culver, Kenneth Offit. CA Cancer J Clin 2011
154
15

Beyond Li Fraumeni Syndrome: clinical characteristics of families with p53 germline mutations.
Kelly D Gonzalez, Katie A Noltner, Carolyn H Buzin, Dongqing Gu, Cindy Y Wen-Fong, Vu Q Nguyen, Jennifer H Han, Katrina Lowstuter, Jeffrey Longmate, Steve S Sommer,[...]. J Clin Oncol 2009
356
15

Routine use of gene panel testing in hereditary breast cancer should be performed with caution.
Cedric van Marcke, Anne De Leener, Martine Berlière, Miikka Vikkula, Francois P Duhoux. Crit Rev Oncol Hematol 2016
14
21

Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer.
Kyriaki Michailidou, Jonathan Beesley, Sara Lindstrom, Sander Canisius, Joe Dennis, Michael J Lush, Mel J Maranian, Manjeet K Bolla, Qin Wang, Mitul Shah,[...]. Nat Genet 2015
365
15

Breast cancer in Mexico: a growing challenge to health and the health system.
Yanin Chávarri-Guerra, Cynthia Villarreal-Garza, Pedro E R Liedke, Felicia Knaul, Alejandro Mohar, Dianne M Finkelstein, Paul E Goss. Lancet Oncol 2012
83
15

Breast cancer phenotype in women with TP53 germline mutations: a Li-Fraumeni syndrome consortium effort.
Serena Masciari, Deborah A Dillon, Michelle Rath, Mark Robson, Jeffrey N Weitzel, Judith Balmana, Stephen B Gruber, James M Ford, David Euhus, Alexandra Lebensohn,[...]. Breast Cancer Res Treat 2012
99
15

Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012.
Jacques Ferlay, Isabelle Soerjomataram, Rajesh Dikshit, Sultan Eser, Colin Mathers, Marise Rebelo, Donald Maxwell Parkin, David Forman, Freddie Bray. Int J Cancer 2015
15


A genome-wide association study of early-onset breast cancer identifies PFKM as a novel breast cancer gene and supports a common genetic spectrum for breast cancer at any age.
Habibul Ahsan, Jerry Halpern, Muhammad G Kibriya, Brandon L Pierce, Lin Tong, Eric Gamazon, Valerie McGuire, Anna Felberg, Jianxin Shi, Farzana Jasmine,[...]. Cancer Epidemiol Biomarkers Prev 2014
62
15

Tumor protein p53 (TP53) testing and Li-Fraumeni syndrome : current status of clinical applications and future directions.
April D Sorrell, Carin R Espenschied, Julie O Culver, Jeffrey N Weitzel. Mol Diagn Ther 2013
60
15

Population-based estimate of the contribution of TP53 mutations to subgroups of early-onset breast cancer: Australian Breast Cancer Family Study.
Judy Mouchawar, Christopher Korch, Tim Byers, Todd M Pitts, Efang Li, Margaret R E McCredie, Graham G Giles, John L Hopper, Melissa C Southey. Cancer Res 2010
67
15

NCCN Guidelines Insights: Genetic/Familial High-Risk Assessment: Breast and Ovarian, Version 2.2017.
Mary B Daly, Robert Pilarski, Michael Berry, Saundra S Buys, Meagan Farmer, Susan Friedman, Judy E Garber, Noah D Kauff, Seema Khan, Catherine Klein,[...]. J Natl Compr Canc Netw 2017
314
15

The European Society of Breast Cancer Specialists recommendations for the management of young women with breast cancer.
Fatima Cardoso, Sibylle Loibl, Olivia Pagani, Alessandra Graziottin, Pietro Panizza, Laura Martincich, Oreste Gentilini, Fedro Peccatori, Alain Fourquet, Suzette Delaloge,[...]. Eur J Cancer 2012
149
15

Hereditary breast cancer: the era of new susceptibility genes.
Paraskevi Apostolou, Florentia Fostira. Biomed Res Int 2013
159
15

The spectrum of genetic mutations in breast cancer.
Asfandyar Sheikh, Syed Ather Hussain, Quratulain Ghori, Nida Naeem, Abul Fazil, Smith Giri, Brijesh Sathian, Prajeena Mainali, Dalal M Al Tamimi. Asian Pac J Cancer Prev 2015
34
15

High prevalence and breast cancer predisposing role of the BLM c.1642 C>T (Q548X) mutation in Russia.
Anna P Sokolenko, Aglaya G Iyevleva, Elena V Preobrazhenskaya, Nathalia V Mitiushkina, Svetlana N Abysheva, Evgeny N Suspitsin, Ekatherina Sh Kuligina, Tatiana V Gorodnova, Werner Pfeifer, Alexandr V Togo,[...]. Int J Cancer 2012
46
10

A CHEK2 genetic variant contributing to a substantial fraction of familial breast cancer.
Pia Vahteristo, Jirina Bartkova, Hannaleena Eerola, Kirsi Syrjäkoski, Salla Ojala, Outi Kilpivaara, Anitta Tamminen, Juha Kononen, Kristiina Aittomäki, Päivi Heikkilä,[...]. Am J Hum Genet 2002
340
10

Exome sequencing identifies rare deleterious mutations in DNA repair genes FANCC and BLM as potential breast cancer susceptibility alleles.
Ella R Thompson, Maria A Doyle, Georgina L Ryland, Simone M Rowley, David Y H Choong, Richard W Tothill, Heather Thorne, Daniel R Barnes, Jason Li, Jason Ellul,[...]. PLoS Genet 2012
137
10


Exome sequencing identifies FANCM as a susceptibility gene for triple-negative breast cancer.
Johanna I Kiiski, Liisa M Pelttari, Sofia Khan, Edda S Freysteinsdottir, Inga Reynisdottir, Steven N Hart, Hermela Shimelis, Sara Vilske, Anne Kallioniemi, Johanna Schleutker,[...]. Proc Natl Acad Sci U S A 2014
121
10

Exome sequencing in a breast cancer family without BRCA mutation.
Jae Myoung Noh, Jihun Kim, Dae Yeon Cho, Doo Ho Choi, Won Park, Seung Jae Huh. Radiat Oncol J 2015
12
16

Protein-truncating variants in moderate-risk breast cancer susceptibility genes: a meta-analysis of high-risk case-control screening studies.
Fatima Aloraifi, Damian McCartan, Trudi McDevitt, Andrew J Green, Adrian Bracken, James Geraghty. Cancer Genet 2015
20
10

Clinical and pathologic characteristics of patients with BRCA-positive and BRCA-negative breast cancer.
Deann P Atchley, Constance T Albarracin, Adriana Lopez, Vicente Valero, Christopher I Amos, Ana Maria Gonzalez-Angulo, Gabriel N Hortobagyi, Banu K Arun. J Clin Oncol 2008
371
10


Initial sequencing and analysis of the human genome.
E S Lander, L M Linton, B Birren, C Nusbaum, M C Zody, J Baldwin, K Devon, K Dewar, M Doyle, W FitzHugh,[...]. Nature 2001
10

Genome-wide association study identifies novel breast cancer susceptibility loci.
Douglas F Easton, Karen A Pooley, Alison M Dunning, Paul D P Pharoah, Deborah Thompson, Dennis G Ballinger, Jeffery P Struewing, Jonathan Morrison, Helen Field, Robert Luben,[...]. Nature 2007
10

CHEK2*1100delC homozygosity is associated with a high breast cancer risk in women.
Muriel A Adank, Marianne A Jonker, Irma Kluijt, Saskia E van Mil, Rogier A Oldenburg, Wolter J Mooi, Frans B L Hogervorst, Ans M W van den Ouweland, Johan J P Gille, Marjanka K Schmidt,[...]. J Med Genet 2011
44
10

Low-penetrance susceptibility to breast cancer due to CHEK2(*)1100delC in noncarriers of BRCA1 or BRCA2 mutations.
Hanne Meijers-Heijboer, Ans van den Ouweland, Jan Klijn, Marijke Wasielewski, Anja de Snoo, Rogier Oldenburg, Antoinette Hollestelle, Mark Houben, Ellen Crepin, Monique van Veghel-Plandsoen,[...]. Nat Genet 2002
791
10


Familial breast cancer.
F Lalloo, D G Evans. Clin Genet 2012
106
10

Germline DNA copy number variation in familial and early-onset breast cancer.
Ana Cv Krepischi, Maria Isabel W Achatz, Erika Mm Santos, Silvia S Costa, Bianca Cg Lisboa, Helena Brentani, Tiago M Santos, Amanda Gonçalves, Amanda F Nóbrega, Peter L Pearson,[...]. Breast Cancer Res 2012
63
10

Global cancer statistics, 2012.
Lindsey A Torre, Freddie Bray, Rebecca L Siegel, Jacques Ferlay, Joannie Lortet-Tieulent, Ahmedin Jemal. CA Cancer J Clin 2015
10

Prevalence of BRCA mutations in an unselected population of triple-negative breast cancer.
Anne-Renee Hartman, Rajesh R Kaldate, Lisa M Sailer, Lisa Painter, Charles E Grier, Robbin R Endsley, Marlena Griffin, Stephanie A Hamilton, Cynthia A Frye, Mark A Silberman,[...]. Cancer 2012
127
10

Pathologic complete response rates in young women with BRCA1-positive breast cancers after neoadjuvant chemotherapy.
Tomasz Byrski, Jacek Gronwald, Tomasz Huzarski, Ewa Grzybowska, Magdalena Budryk, Malgorzata Stawicka, Tomasz Mierzwa, Marek Szwiec, Rafal Wisniowski, Monika Siolek,[...]. J Clin Oncol 2010
385
10

Expanding the criteria for BRCA mutation testing in breast cancer survivors.
Janice S Kwon, Angelica M Gutierrez-Barrera, Diana Young, Charlotte C Sun, Molly S Daniels, Karen H Lu, Banu Arun. J Clin Oncol 2010
103
10

Incidence and outcome of BRCA mutations in unselected patients with triple receptor-negative breast cancer.
Ana M Gonzalez-Angulo, Kirsten M Timms, Shuying Liu, Huiqin Chen, Jennifer K Litton, Jennifer Potter, Jerry S Lanchbury, Katherine Stemke-Hale, Bryan T Hennessy, Banu K Arun,[...]. Clin Cancer Res 2011
366
10

Involvement of Brca2 in DNA repair.
K J Patel, V P Yu, H Lee, A Corcoran, F C Thistlethwaite, M J Evans, W H Colledge, L S Friedman, B A Ponder, A R Venkitaraman. Mol Cell 1998
500
10

Germline mutations in BRCA1 and BRCA2 in breast-ovarian families from a breast cancer risk evaluation clinic.
A M Martin, M A Blackwood, D Antin-Ozerkis, H A Shih, K Calzone, T A Colligon, S Seal, N Collins, M R Stratton, B L Weber,[...]. J Clin Oncol 2001
66
10

Activity of trabectedin in germline BRCA1/2-mutated metastatic breast cancer: results of an international first-in-class phase II study.
S Delaloge, R Wolp-Diniz, T Byrski, J L Blum, A Gonçalves, M Campone, P Lardelli, C Kahatt, A Nieto, M Cullell-Young,[...]. Ann Oncol 2014
29
10

BRCA2 is required for homology-directed repair of chromosomal breaks.
M E Moynahan, A J Pierce, M Jasin. Mol Cell 2001
708
10

Effects of BRCA1- and BRCA2-related mutations on ovarian and breast cancer survival: a meta-analysis.
Qian Zhong, Hong-Ling Peng, Xia Zhao, Lin Zhang, Wei-Ting Hwang. Clin Cancer Res 2015
116
10


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.